NCT01621633View on ClinicalTrials.gov

A Study of LCZ696 in Subjects With Mild and Moderate Hepatic Impairment Compared With Normal Healthy Volunteers

PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
Hepatic Impairment
Interventions
DRUG

LCZ696

Trial Locations (1)

D-67269

Novartis Investigative Site, Grünstadt

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY